(Q39123810)

9 September 2017

title

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway (English)

1 reference

9 September 2017

1 reference

1 reference

Rong Li

1

1 reference

9 September 2017

Arthur C K Chung

2

1 reference

9 September 2017

Yuan Dong

3

1 reference

9 September 2017

Weiqin Yang

4

1 reference

9 September 2017

Xiang Zhong

5

1 reference

9 September 2017

Hui Y Lan

6

1 reference

9 September 2017

language of work or name

English

0 references

publication date

17 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

84

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

1129-1144

1 reference

Pathophysiology of Progressive Nephropathies

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Mechanisms of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

The importance of tubulointerstitial damage in progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

TGF-beta signal transduction and mesangial cell fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Mechanisms of kidney fibrosis and the role of antifibrotic therapies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

TGF-β/Smad signaling in kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Transforming growth factor-β and Smads

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Smad3-mediated upregulation of miR-21 promotes renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

MicroRNAs as mediators and therapeutic targets in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Mechanism of chronic aristolochic acid nephropathy: role of Smad3.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

rVISTA 2.0: evolutionary analysis of transcription factor binding sites

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

miRDB: a microRNA target prediction and functional annotation database with a wiki interface

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

The microRNA.org resource: targets and expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

A guide through present computational approaches for the identification of mammalian microRNA targets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Chemokines in renal injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

The role of polyamines in supporting growth of mammalian cells is mediated through their requirement for translation initiation and elongation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Role of the TGF-β/BMP-7/Smad pathways in renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Down-regulated miR-9 and miR-433 in human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Identification of differentially expressed genes in normal and tumor human gastric tissue.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Polyamines modulate epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Latent TGF-beta1 protects against crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Deletion of exon I of SMAD7 in mice results in altered B cell responses.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Antizyme affects cell proliferation and viability solely through regulating cellular polyamines

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.272

7 January 2021

Identifiers

DOI

10.1038/KI.2013.272

1 reference

9 September 2017

1 reference